Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 3
This trial is comparing 3 different doses of aspirin as a way of stopping cancer developing in people who have Lynch syndrome.
Cancer Research UK supports this trial.
Recruitment start: 1 October 2014
Recruitment end: 31 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sir John Burn
Bayer Pharma AG
Cancer Research UK
NIHR Clinical Research Network: Genetics
Newcastle University
Newcastle upon Tyne Hospitals NHS Foundation Trust
This is Cancer Research UK trial number CRUK/12/039.
There is more information on the CaPP3 website(link is external).
Last reviewed: 25 May 2022
CRUK internal database number: 10517
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
